Family · Pharmaceutical analytical standards
Pemafibrate
A selective PPAR-alpha modulator (SPPARMα), related to the fibrates, approved in Japan in 2017 for hyperlipidaemia: it lowers triglycerides and raises HDL cholesterol. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It was designed to be far more selective than traditional fibrates and, unlike them, which are cleared mainly by the kidneys, it is eliminated mainly by the liver.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
